Document:

<PAGE>   1
                                                                 Exhibit 10.1

              AMENDED FORM OF U.S. MANUFACTURER'S REPRESENTATIVE
                                  AGREEMENT

This agreement is effective ___________and is by and between Gliatech Medical,
an Ohio corporation, having offices at 23420 Commerce Park Road, Cleveland, Ohio
44122, (hereinafter "Gliatech"), and [CompanyName] a corporation, having
offices at [CorrAddress], [Expr2] (hereinafter "Manufacturers
Representative").

WHEREAS, Gliatech markets and sells a medical device, ADCON(R)-L Anti-Adhesion
Barrier Gel (the "Product") to the medical industry; and

WHEREAS, Manufacturers Representative promotes sales of products, including
medical devices such as instruments, implants and supplies, to the medical
industry; and

WHEREAS, Gliatech desires to appoint Manufacturers Representative as an
independent representative for promoting sales of the Product manufactured and
distributed by Gliatech, and Manufacturers Representative desires to be an
appointed independent representative for promoting sales of the Product;

NOW, THEREFORE, in consideration of the premises and covenants herein contained,
the parties hereto agree as follows:

1.       APPOINTMENT OF MANUFACTURERS REPRESENTATIVE

         Gliatech hereby appoints, and Manufacturers Representative hereby
         accepts, the appointment as the exclusive, independent representative
         of Gliatech for the promotion of sales of the Product for the Territory
         (as defined below) designated. Gliatech shall have the right to amend,
         from time to time, the Territory as defined in Appendix 2, upon 30 days
         written notice to the Manufacturers Representative. Manufacturers
         Representative shall not sell or solicit sales of products or otherwise
         represent companies selling or otherwise distributing products
         competitive to Gliatech's products without prior written approval from
         Gliatech. Gliatech shall have the sole right to make the determination
         of those products which are competitive to Gliatech's products. Subject
         to the terms of this Agreement, Manufacturer's Representative is free
         to engage in any other activities it wishes.

2.       TERRITORY

         The Territory specified hereunder within which the Manufacturer's
         Representative shall solicit sales of the Product shall be the
         geographical area shown in Appendix 2 attached hereto (the
         "Territory").

                                       1
<PAGE>   2

3.       MANUFACTURERS REPRESENTATIVE'S DUTIES AND OBLIGATIONS

         A.       Manufacturers Representative shall promote the Product and
                  solicit orders for sales of the Product within the Territory.
                  Promotional activity shall include, but not be limited to,
                  Product display advertising and promotion at medical doctor or
                  hospital meetings and exhibitions, such as conventions and
                  trade shows, and state and regional medical or hospital
                  meetings. Manufacturers Representative shall appoint employee
                  sales representatives (the "Sales Representatives") to assist
                  in the promotion and sale of the Product. The Sales
                  Representative shall be the sole responsibility of
                  Manufacturer's Representative who shall (i) ensure the filing
                  of all appropriate business registrations, (ii) compliance
                  with the requirements of tax withholding and reporting
                  occasioned by the engagement of such Sales Representatives and
                  (iii) compliance by such Sales Representatives with all
                  obligations of Manufacturers Representative hereunder.

         B.       Manufacturers' Representative shall be responsible for
                  assuring its Sales Representatives are thoroughly trained to
                  promote and sell the Product consistent with the training
                  guidelines provided by Gliatech.

         C.       Manufacturers' Representative sole compensation for services
                  provided hereunder shall be compensation in the form of a
                  commission on the sale of the Product in the Territory.

         D.       In order to comply with applicable law and in order to protect
                  Gliatech from claims and liabilities, Manufacturers
                  Representatives communications and representations to
                  customers shall be true, accurate, complete and consistent
                  with the labeling of the Product. Manufacturers Representative
                  shall under no circumstances modify, repackage, adulterate,
                  misbrand, alter or add labels to or remove labels from the
                  Product.

         E.       All advertising and all participation by Manufacturers
                  Representative in public exhibitions, relating to the Product
                  and the use of Gliatech's name and trademarks, shall be
                  subject to prior written approval of Gliatech, which approval
                  shall not be unreasonably withheld.

         F.       Manufacturers Representative's sales quota for the
                  ______________________ are set forth in Appendix 1 attached
                  hereto. Manufacturers Representative shall receive its
                  proposed sales quota for any subsequent year no later than
                  December 1. Achievement of the annual and quarterly sales
                  quotas is a material obligation of this Agreement.

                                       2
<PAGE>   3

         G.       Except as otherwise agreed, Manufacturers Representative shall
                  be responsible for providing its own equipment, offices,
                  working facilities and such other facilities and services as
                  may be required at its own expense. Manufacturers
                  Representative shall maintain an inventory of demonstration
                  equipment, and deliverable Product (the "Inventory") to
                  promote and solicit orders for Product. Manufacturer's
                  Representative shall be responsible for the risk of loss or
                  damage of such Inventory whether or not held at Manufacturers
                  Representatives business location. Manufacturers
                  Representative will be charged for each lost unit of Product
                  at the average selling price per unit for its Territory for
                  that year, less its commission. Upon termination of this
                  Agreement, Inventory of Product shall be returned to Gliatech.

         H.       Manufacturer's Representative and all sales representatives
                  shall attend one national sales meeting per year for the
                  purposes of training related to the promotion of the Product.

         I.       Manufacturer's Representative shall submit an annual
                  comprehensive Business Plan as set forth in Appendix 4,
                  attached hereto.

         J.       The authorized person executing this Agreement on behalf of
                  the Manufacturer's Representative shall be personally, as an
                  individual, liable to see that the Manufacturer's
                  Representative meets all of its obligations herein.

         K.       Manufacturer's Representative shall not make any
                  representation or statement, written or otherwise, concerning
                  prices, terms of delivery, terms of payment or conditions of
                  sale except and to the extent that the same is specifically
                  authorized by Gliatech. Manufacturers Representative shall
                  have no right or authority to make any price guarantees, offer
                  or agree to any discounts and/or accept any orders on
                  Gliatech's behalf or return any products to Gliatech without
                  prior written approval by Gliatech.

4.       GLIATECH DUTIES AND OBLIGATIONS

         A.       Gliatech shall sell and deliver the Product with respect to
                  orders solicited by Manufacturer's Representative in
                  accordance with published price lists in effect. Gliatech may
                  accept or refuse any order for the Product and will not be
                  bound by any order until it is finally accepted by Gliatech.
                  Gliatech shall not be liable for any loss or damage caused by
                  non-acceptance of orders or delays in making shipments.

         B.       Gliatech shall pay a commission to Manufacturer's
                  Representative on orders solicited within and delivered to the
                  Territory as set forth in Appendix 3 attached hereto (which
                  may be from time to time amended).

                                       3
<PAGE>   4

                  Commissions shall be deemed earned by Manufacturer's
                  Representative upon invoicing of Product sales by Gliatech to
                  customers. Commissions earned by Manufacturers Representative
                  shall be computed on the net amount of the invoices rendered
                  (less credit memos) in accordance with published price lists
                  for each order or part of an order, exclusive of all freight
                  and transportation costs (including insurance), normal and
                  recurring bona fide trade discounts having Gliatech's prior
                  written approval and any applicable sales or similar taxes.

                  Commissions earned by the Manufacturers Representative shall
                  be due and payable on or before the 25th day of the month
                  immediately following the month during which invoices are
                  issued for orders received by Gliatech.

         C.       Gliatech shall forward to Manufacturers Representative those
                  inquiries for the Product which are reasonably identifiable as
                  having been generated through the advertising or sales
                  promotion efforts of Manufacturers Representative or any of
                  its Sales Representatives.

         D.       Subject to reasonable charges as determined by Gliatech,
                  Gliatech shall supply Manufacturers Representative with
                  reasonable quantities of descriptive literature, promotional
                  and other materials (the "Promotional Literature") relating to
                  the Product.

         E.       Gliatech shall indemnify Manufacturers Representative, its
                  employees and Sales Representatives against any and all third
                  party claims and demands for losses, damages and injuries,
                  including legal expenses and attorneys fees, arising out of
                  any claim of a defect in the manufacture or design of the
                  Product or written representation or omission in Gliatech's
                  Promotional Literature concerning the Product. This indemnity
                  shall not extend to any malfeasance, nonfeasance or other
                  negligent conduct of Manufacturers Representative, its
                  employees or Sales Representatives in connection with any acts
                  related to the Manufacturers Representative's activity
                  hereunder. Except as otherwise expressly provided,
                  Manufacturers Representative is liable for all its own
                  expenses and all claims made against it.

         F.       Gliatech shall make a good faith effort to collect monies owed
                  on invoices from orders solicited by Manufacturers
                  Representative and shall provide Manufacturers Representative
                  with a monthly statement of past due accounts in the
                  Territory. In the event that Gliatech has not received payment
                  from any customer upon which a commission was paid within one
                  hundred twenty (120) days from the date on which any payment
                  was due, Gliatech reserves the right to charge back to the
                  Manufacturers Representative the full amount of the commission
                  paid on such sale.

                                       4
<PAGE>   5

                  Upon subsequent receipt of the outstanding monies, Gliatech
                  will pay the original commission amount.

5.       CONFIDENTIALITY,  IMPROVEMENTS,  PATENTS  AND  TRADEMARKS

         A.       Manufacturers Representative shall take all reasonable steps
                  to do those things reasonably necessary to ensure that
                  confidential information relating to the Product and to the
                  technology and business of Gliatech is not disclosed or made
                  use of outside the business of Manufacturers Representative
                  and Gliatech including, without limitation, causing such Sales
                  Representative to maintain the confidential information;
                  provided, however, that the foregoing shall not apply to
                  information (a) which be can shown to be in writing and known
                  to Manufacturers Representative prior to disclosure by
                  Gliatech; (b) which is or becomes public knowledge through no
                  fault of Manufacturers Representative; or (c) which is
                  disclosed to Manufacturers Representative by a third party
                  with the lawful right to make such disclosure. Manufacturers
                  Representative's obligation of confidentiality shall survive
                  the termination of this Agreement until and unless such
                  confidential information shall have become, through no fault
                  of the Manufacturers Representative, generally in the public
                  domain.

         B.       During the term of this agreement Manufacturers Representative
                  shall be permitted to use Gliatech's servicemark, trademarks
                  and identification solely on or in connection with the
                  solicitation of orders for the Product during the term of this
                  Agreement. It is the obligation of the Manufacturers
                  Representative to notify Gliatech of any infringement of
                  Gliatech's trademarks and identification. Manufacturers
                  Representative shall discontinue the use of all such marks
                  upon the termination of this Agreement. All goodwill generated
                  hereunder in the use of such trademarks shall accrue to the
                  benefit of Gliatech. The Manufacturers Representative hereby
                  disclaims any rights in Gliatech's trademarks and
                  identification other than the aforementioned use.

6.       TERMS AND TERMINATION

         A.       This Agreement shall continue in full force and effect
                  beginning on April 1, 2000 and continuing through December 31,
                  2000. This Agreement shall thereafter automatically renew for
                  additional yearly periods unless written notice is made by
                  either party 30 days prior to expiration, provided however
                  that as of December 1, the parties hereto have agreed to a
                  sales quota per Section 3 (F) hereto.

         B.       Gliatech shall have the right to terminate this Agreement if
                  the sales quota as determined by Gliatech and specified in
                  Appendix 1 is not achieved. In

                                       5
<PAGE>   6

                  this case, Gliatech will provide Manufacturers Representative
                  30 days written notice prior to termination.

         C.       Gliatech shall have the right to terminate this Agreement upon
                  notice of Manufacturers Representative's (i) commission or
                  suffering of any act of bankruptcy or insolvency, (ii) failing
                  to cure any material breach in the provisions of this
                  agreement within thirty (30) days after written notice of such
                  breach, except as otherwise provided by Section 6(B), (iii)
                  conviction in any court of a felony under applicable city,
                  state, or federal laws.

         D.       If this Agreement shall terminate for any reason whatsoever,
                  the Manufacturers Representative shall be entitled to receive
                  commissions as determined in accordance with the above
                  provisions with respect to orders solicited prior to the
                  effective date of such termination, regardless of when such
                  orders were accepted by Gliatech (provided such orders can be
                  demonstrated to be orders that were solicited prior to the
                  effective date of such termination) and regardless of when
                  such shipments are made and invoices rendered.

         E.       Goods returned according to Gliatech's Customer Returns Policy
                  as set forth in Appendix 5 hereto, shall be charged against
                  Manufacturers Representative commission payable. Ninety days
                  (90) after termination of this agreement, the commission
                  account shall be closed and all proceeds over the uncollected
                  accounts receivable shall be paid to the Manufacturers
                  Representative.

7.       FORCE MAJEURE

         Obligations of either party to perform under this Agreement shall be
         excused and, in Manufacturers Representative's case, sales quotas
         addressed in Section 3(F) hereof will be reduced proportionately during
         such period of delay caused by matters such as strikes, shortages of
         power or raw materials, government orders, or Acts of God, which are
         reasonably beyond the control of the party obligated to perform.

8.       NOTICES

         Any notice required by this Agreement shall be deemed sufficient if
         sent by certified mail, postage prepaid, facsimile transmission or
         overnight courier to the party to be notified at the address set forth
         below, until a different address is supplied in writing.

         In the case of Gliatech, such notice shall be sent to:

                                            Gliatech Inc.

                                       6
<PAGE>   7

                                           23420 Commerce Park Road
                                           Cleveland, Ohio 44122
                                           Attn: Thomas O. Oesterling, Ph.D.
                                           Fax: 216-831-4220

         In the case of Manufacturers Representative, such notice shall be sent
to:

                                            Fax:

9.       ENTIRE AGREEMENT

         This document and the Appendices attached hereto and incorporated
         herein by reference thereto represent the entire agreement between the
         parties hereto, and supersede all prior agreements regardless of their
         terms or cancellation provisions, and this Agreement shall be modified
         only by a written agreement signed by Gliatech and the Manufacturers
         Representative.

10.      APPLICABLE LAW

         This Agreement shall be governed by the laws of the State of Ohio as
         applicable to contracts made and to be performed in that state.

11.      ASSIGNABILITY

         This agreement shall not be assigned either by the parties or by
         operation of law without prior written consent of the other party;
         however, in the case of Gliatech, Gliatech may, without obtaining the
         consent of the Manufacturers Representative, assign its rights and
         obligations under this Agreement to any corporation with which Gliatech
         may merge or consolidate or to which Gliatech may transfer
         substantially all of its assets.

                                       7

<PAGE>   8

IN WITNESS WHEREOF, the parties hereto have executed this Agreement effective as
of the First day of April 2000.

GLIATECH MEDICAL INC.                         [CompanyName]

By:__________________________________          By: ____________________________

       Thomas O. Oesterling, Ph.D.             Name:___________________________
  Chairman and Chief Executive Officer

                                       8<PAGE>   1
EMPLOYMENT AGREEMENT                                                       10(e)

     AGREEMENT by and between COMPASS BANCSHARES, INC., a Delaware corporation
(the "Company"), and D. PAUL JONES, JR. (the "Executive"), dated December 14,
1994.

     The Board of Directors of the Company (the "Board"), has determined that it
is in the best interests of the Company and its shareholders to assure that the
Company will have the continued dedication of the Executive, notwithstanding the
possibility, threat or occurrence of a Change of Control (as defined in Section
2) of the Company.  The Board believes it is imperative to diminish the
inevitable distraction of the Executive by virtue of the personal uncertainties
and risks created by a pending or threatened Change of Control and to encourage
the Executive's full attention and dedication to the Company currently and in
the event of any threatened or pending Change of Control, and to provide the
Executive with compensation and benefits arrangements upon a Change of Control
which ensure that the compensation and benefits expectations of the Executive
will be satisfied and which are competitive with those of other corporations.
Therefore, in order to accomplish these objectives, the Board has caused the
Company to enter into this Agreement.

     NOW, THEREFORE, IT IS HEREBY AGREED AS FOLLOWS:

     1.  CERTAIN DEFINITIONS.

         (a) The "Effective Date" shall mean the first date during the Change
     of Control Period (as defined in Section 1(b)) on which a Change of Control
     occurs.  Anything in this Agreement to the contrary notwithstanding, if a
     Change of Control occurs and if the Executive's employment with the Company
     is terminated prior to the date on which the Change of Control occurs, and
     if it is reasonably demonstrated by the Executive that such termination of
     employment (i) was at the request of a third party who has taken steps
     reasonably calculated to effect the Change of Control or (ii) otherwise
     arose in connection with or anticipation of the Change of Control, then for
     all purposes of this Agreement the "Effective Date" shall mean the date
     immediately prior to the date of such termination of employment.

         (b) The "Change of Control Period" shall mean the period commencing on
     the date hereof and ending on the third anniversary of such date; provided,
     however, that commencing on the date one year after the date hereof, and on
     each annual anniversary of such date (such date and each annual anniversary
     thereof shall be hereinafter referred to as the "Renewal Date"), the Change
     of Control Period shall be automatically extended so as to terminate three
     years from such Renewal Date, unless at least 60 days prior to the Renewal
     Date the Company shall give notice to the Executive that the Change of
     Control Period shall not be so extended.

     2.  CHANGE OF CONTROL.  For the purpose of this Agreement, a "Change of
Control" shall mean:

<PAGE>   2

         (a) The acquisition by any individual, entity or group (within the
     meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of
     1934, as amended (the "Exchange Act")) (a "Person") of beneficial ownership
     (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of
     20% or more of either (i) the then outstanding shares of common stock of
     the Company (the "Outstanding Company Common Stock") or (ii) the combined
     voting power of the then outstanding voting securities of the Company
     entitled to vote generally in the election of directors (the "Outstanding
     Company Voting Securities"); provided, however, that the following
     acquisitions shall not constitute a Change of Control:  (i) any acquisition
     directly from the Company (excluding an acquisition by virtue of the
     exercise of a conversion privilege), (ii) any acquisition by the Company,
     (iii) any acquisition by any employee benefit plan (or related trust)
     sponsored or maintained by the Company or any corporation controlled by the
     Company or (iv) any acquisition by any corporation pursuant to a
     reorganization, merger or consolidation, if, following such reorganization,
     merger or consolidation, the conditions described in clauses (i), (ii) and
     (iii) of subsection (c) of this Section 2 are satisfied; or

         (b) Individuals who, as of the date hereof, constitute the Board (the
     "Incumbent Board") cease for any reason to constitute at least a majority
     of the Board; provided, however, that any individual becoming a director
     subsequent to the date hereof whose election, or nomination for election by
     the Company's shareholders, was approved by a vote of at least a majority
     of the directors then comprising the Incumbent Board shall be considered as
     though such individual were a member of the Incumbent Board, but excluding,
     for this purpose, any such individual whose initial assumption of office
     occurs as a result of either an actual or threatened election contest (as
     such terms are used in Rule 14a-11 of Regulation 14A promulgated under the
     Exchange Act) or other actual or threatened solicitation of proxies or
     consents by or on behalf of a Person other than the Board; or

         (c) Approval by the shareholders of the Company of a reorganization,
     merger or consolidation, in each case, unless, following such
     reorganization, merger or consolidation, (i) more than 60% of,
     respectively, the then outstanding shares of common stock of the
     corporation resulting from such reorganization, merger or consolidation and
     the combined voting power of the then outstanding voting securities of such
     corporation entitled to vote generally in the election of directors is then
     beneficially owned, directly or indirectly, by all or substantially all of
     the individuals and entities who were the beneficial owners, respectively,
     of the Outstanding Company Common Stock and Outstanding Company Voting
     Securities immediately prior to such reorganization,

                                       2
<PAGE>   3

     merger or consolidation in substantially the same proportions as their
     ownership, immediately prior to such reorganization, merger or
     consolidation, of the Outstanding Company Common Stock and Outstanding
     Company Voting Securities, as the case may be, (ii) no Person (excluding
     the Company, any employee benefit plan (or related trust) of the Company or
     such corporation resulting from such reorganization, merger or
     consolidation and any Person beneficially owning, immediately prior to such
     reorganization, merger or consolidation, directly or indirectly, 20% or
     more of the Outstanding Company Common Stock or Outstanding Voting
     Securities, as the case may be) beneficially owns, directly or indirectly,
     20% or more of, respectively, the then outstanding shares of common stock
     of the corporation resulting from such reorganization, merger or
     consolidation or the combined voting power of the then outstanding voting
     securities of such corporation entitled to vote generally in the election
     of directors and (iii) at least a majority of the members of the board of
     directors of the corporation resulting from such reorganization, merger or
     consolidation were members of the Incumbent Board at the time of the
     execution of the initial agreement providing for such reorganization,
     merger or consolidation; or

         (d) Approval by the shareholders of the Company of (i) a complete
     liquidation or dissolution of the Company or (ii) the sale or other
     disposition of all or substantially all of the assets of the Company, other
     than to a corporation, with respect to which following such sale or other
     disposition, (A) more than 60% of, respectively, the then outstanding
     shares of common stock of such corporation and the combined voting power of
     the then outstanding voting securities of such corporation entitled to vote
     generally in the election of directors is then beneficially owned, directly
     or indirectly, by all or substantially all of the individuals and entities
     who were the beneficial owners, respectively, of the Outstanding Company
     Common Stock and Outstanding Company Voting Securities immediately prior to
     such sale or other disposition in substantially the same proportion as
     their ownership, immediately prior to such sale or other disposition, of
     the Outstanding Company Common Stock and Outstanding Company Voting
     Securities, as the case may be, (B) no Person (excluding the Company and
     any employee benefit plan (or related trust) of the Company or such
     corporation and any Person beneficially owning, immediately prior to such
     sale or other disposition, directly or indirectly, 20% or more of the
     Outstanding Company Common Stock or Outstanding Company Voting Securities,
     as the case may be) beneficially owns, directly or indirectly, 20% or more
     of, respectively, the then outstanding shares of common stock of such
     corporation and the combined voting power of the then outstanding voting
     securities of such corporation entitled to vote generally in the election
     of directors and (C) at least a majority of the members of the board of
     directors of such corporation were members of the Incumbent Board at the
     time of the execution of the initial agreement or action of the Board
     providing for such sale or other disposition of assets of the Company.

                                       3
<PAGE>   4

     3.   EMPLOYMENT PERIOD.  The Company hereby agrees to continue the
Executive in its employ, and the Executive hereby agrees to remain in the employ
of the Company, in accordance with the terms and provisions of this Agreement,
for the period commencing on the Effective Date and ending on the third
anniversary of such date (the "Employment Period"). Nothing contained herein
shall be construed as conferring upon the Executive any right to continue to be
employed by the Company prior to the Effective Date, as defined in Section 1(a),
unless this agreement is modified in writing as provided for in Section 11(a).

     4.   TERMS OF EMPLOYMENT.

          (a)  Position and Duties.
               -------------------

               (i) During the Employment Period, (A) the Executive's position
          (including status, offices, titles and reporting requirements),
          authority, duties and responsibilities shall be at least commensurate
          in all material respects with the most significant of those held,
          exercised and assigned at any time during the 90-day period
          immediately preceding the Effective Date and (B) the Executive's
          services shall be performed at the location where the Executive was
          employed immediately preceding the Effective Date.

               (ii) During the Employment Period, and excluding any periods of
          vacation and sick leave to which the Executive is entitled, the
          Executive agrees to devote reasonable attention and time during normal
          business hours to the business and affairs of the Company and, to the
          extent necessary to discharge the responsibilities assigned to the
          Executive hereunder, to use the Executive's reasonable best efforts to
          perform faithfully and efficiently such responsibilities.  To the
          extent permitted by the Code of Conduct of the Company then applicable
          during the Employment Period it shall not be a violation of this
          Agreement for the Executive to (A) serve on corporate, civic or
          charitable boards or committees, (B) deliver lectures, fulfill
          speaking engagements or teach at educational institutions and (C)
          manage personal investments, so long as such activities do not
          significantly interfere with the performance of the Executive's
          responsibilities as an employee of the Company in accordance with this
          Agreement.  It is expressly understood and agreed that to the extent
          that any such activities were permitted by the Code of Conduct prior
          to the Effective Date and have been conducted by the Executive prior
          to the Effective Date, the continued conduct of such activities (or
          the conduct of activities similar in nature and scope thereto)
          subsequent to the Effective Date shall not thereafter be deemed to
          interfere with the performance of the Executive's responsibilities to
          the Company.

          (b)  Compensation.
               ------------

                                       4
<PAGE>   5

               (i) BASE SALARY.  During the Employment Period, the Executive
          shall receive an annual base salary ("Annual Base Salary"), which
          shall be paid in equal installments on a bi-monthly basis, at least
          equal to twenty-four times the highest bi-monthly base salary paid or
          payable to the Executive by the Company or its affiliated companies in
          respect of the twelve-month period immediately preceding the month in
          which the Effective Date occurs.  During the Employment Period, the
          Annual Base Salary shall be reviewed at least annually and shall be
          increased at any time and from time to time as shall be substantially
          consistent with increases in base salary generally awarded in the
          ordinary course of business to other peer executives of the Company
          and its affiliated companies.  Any increase in Annual Base Salary
          shall not serve to limit or reduce any other obligation to the
          Executive under this Agreement.  Annual Base Salary shall not be
          reduced after any such increase and the term Annual Base Salary as
          utilized in this Agreement shall refer to Annual Base Salary as so
          increased.  As used in this Agreement, the term "affiliated companies"
          shall include any company controlled by, controlling or under common
          control with the Company.

               (ii) ANNUAL BONUS.  In addition to Annual Base Salary, the
          Executive shall be awarded, for each calendar year ending during the
          Employment Period, an annual bonus (the "Annual Bonus") in cash at
          least equal to the greater of (A) the annualized bonus payable to the
          Executive for the year in which the Effective Date occurs or (B) the
          average annualized (for any year with respect to which the Executive
          has been employed by the Company for less than twelve full months)
          bonus paid or payable, including by reason of any deferral, to the
          Executive by the Company and its affiliated companies in respect of
          the three calendar years immediately preceding the calendar year in
          which the Effective Date occurs (the "Recent Average Bonus").  Each
          such Annual Bonus shall be paid no later than the end of February of
          the year next following the year for which the Annual Bonus is
          awarded, unless the Executive shall elect to defer the receipt of such
          Annual Bonus.

               (iii)  INCENTIVE, SAVINGS AND RETIREMENT PLANS.  During the
          Employment Period, the Executive shall be entitled to participate in
          all incentive, savings and retirement plans, practices, policies and
          programs applicable generally to other peer executives of the Company
          and its affiliated companies, but in no event shall such plans,
          practices, policies and programs provide the Executive with incentive
          opportunities (measured with respect to both regular and special
          incentive opportunities, to the extent, if any, that such distinction
          is applicable), savings opportunities and retirement benefit
          opportunities, in each case, less favorable, in the aggregate, than
          the most favorable of those provided by the Company and its affiliated
          companies for the Executive under such plans, practices, policies and
          programs as in effect at any time during the 90-day period immediately
          preceding

                                       5
<PAGE>   6

          the Effective Date or if more favorable to the Executive, those
          provided generally at any time after the Effective Date to other peer
          executives of the Company and its affiliated companies.

               (iv) LEAVE PROGRAMS.  During the Employment Period, the Executive
          shall be eligible for participation in and shall receive all benefits
          under leave programs provided by the Company and its affiliated
          companies (including, without limitation, sick leave, short-term
          disability, emergency leave, jury duty, military leave, and family and
          medical leave) to the extent applicable generally to other peer
          executives of the Company and its affiliated companies, but in no
          event shall such programs provide the Executive with benefits which
          are less favorable, in the aggregate, than the most favorable of such
          programs in effect for the Executive at any time during the 90-day
          period immediately preceding the Effective Date or, if more favorable
          to the Executive, those provided generally at any time after the
          Effective Date to other peer executives of the Company and its
          affiliated companies.

               (v) WELFARE BENEFIT PLANS.  During the Employment Period, the
          Executive and/or the Executive's family, as the case may be, shall be
          eligible for participation in and shall receive all benefits under
          welfare benefit plans, practices, policies and programs provided by
          the Company and its affiliated companies (including, without
          limitation, medical, prescription, dental, disability, salary
          continuance, employee life, group life, accidental death and travel
          accident insurance plans and programs) to the extent applicable
          generally to other peer executives of the Company and its affiliated
          companies, but in no event shall such plans, practices, policies and
          programs provide the Executive with benefits which are less favorable,
          in the aggregate, than the most favorable of such plans, practices,
          policies and programs in effect for the Executive at any time during
          the 90-day period immediately preceding the Effective Date or, if more
          favorable to the Executive, those provided generally at any time after
          the Effective Date to other peer executives of the Company and its
          affiliated companies.

               (vi) EXPENSES.  During the Employment Period, the Executive shall
          be entitled to receive prompt reimbursement for all reasonable
          employment expenses incurred by the Executive in accordance with the
          most favorable policies, practices and procedures of the Company and
          its affiliated companies in effect for the Executive at any time
          during the 90-day period immediately preceding the Effective Date or,
          if more favorable to the Executive, as in effect generally at any time
          thereafter with respect to other peer executives of the Company and
          its affiliated companies.

                                       6
<PAGE>   7

               (vii)  FRINGE BENEFITS.  During the Employment Period, the
          Executive shall be entitled to fringe benefits in accordance with the
          most favorable plans, practices, programs and policies of the Company
          and its affiliated companies in effect for the Executive at any time
          during the 90-day period immediately preceding the Effective Date or,
          if more favorable to the Executive, as in effect generally at any time
          thereafter with respect to other peer executives of the Company and
          its affiliated companies.

               (viii)  OFFICE AND SUPPORT STAFF.  During the Employment Period,
          the Executive shall be entitled to an office or offices of a size and
          with furnishings and other appointments, and to exclusive personal
          secretarial and other assistance, at least equal to the most favorable
          of the foregoing provided to the Executive by the Company and its
          affiliated companies at any time during the 90-day period immediately
          preceding the Effective Date or, if more favorable to the Executive,
          as provided generally at any time thereafter with respect to other
          peer executives of the Company and its affiliated companies.

               (ix) VACATION.  During the Employment Period, the Executive shall
          be entitled to paid vacation and other vacation benefits in accordance
          with the most favorable plans, policies, programs and practices of the
          Company and its affiliated companies as in effect for the Executive at
          any time during the 90-day period immediately preceding the Effective
          Date or, if more favorable to the Executive, as in effect generally at
          any time thereafter with respect to other peer executives of the
          Company and its affiliated companies.

     5.   TERMINATION OF EMPLOYMENT.

          (a) DEATH OR DISABILITY.  The Executive's employment shall terminate
     automatically upon the Executive's death during the Employment Period.  If
     the Company determines in good faith that the Disability of the Executive
     has occurred and has continued for a period of 180 consecutive days during
     the Employment Period (pursuant to the definition of Disability set forth
     below), it may give to the Executive written notice in accordance with
     Section 12(b) of its intention to terminate the Executive's employment.  In
     such event, the Executive's employment with the Company shall terminate
     effective on the 30th day after receipt of such notice by the Executive
     (the "Disability Effective Date"), provided that, within the 30 days after
     such receipt, the Executive shall not have returned to full-time
     performance of the Executive's duties.  For purposes of this Agreement, a
     "Disability" shall occur when a physician confirms, because of sickness or
     injury, that the Executive cannot perform each of the material duties of
     his or her regular occupation.

                                       7
<PAGE>   8

          (b) CAUSE.  The Company may terminate the Executive's employment
     during the Employment Period for Cause.  For purposes of this Agreement,
     "Cause" shall include (i) a willful and material violation of applicable
     banking laws and regulations, (ii) dishonesty, (iii) theft, (iv) fraud, (v)
     embezzlement, (vi) commission of a felony or a crime involving moral
     turpitude, (vii) substantial dependence or addiction to alcohol or any
     drug, (viii) conduct disloyal to the Company or its affiliates or (ix)
     willful disregard of lawful instructions or directions of the officers or
     directors of the Company or its affiliates relating to a material matter.

          (c) GOOD REASON; WINDOW PERIOD.  The Executive's employment may be
     terminated (i) during the Employment Period by the Executive for Good
     Reason or (ii) during the Window Period by the Executive without any
     reason.  For purposes of this Agreement, the "Window Period" shall mean the
     30-day period immediately following the first anniversary of the Effective
     Date.  For purposes of this Agreement, "Good Reason" shall mean:

               (i) the assignment to the Executive of any duties inconsistent in
          any respect with the Executive's position (including status, offices,
          titles and reporting requirements), authority, duties or
          responsibilities as contemplated by Section 4(a) or any other action
          by the Company which results in a diminution in such position,
          authority, duties or responsibilities, excluding for this purpose an
          isolated, insubstantial and inadvertent action not taken in bad faith
          and which is remedied by the Company promptly after receipt of notice
          thereof given by the Executive;

               (ii) any failure by the Company to comply with any of the
          provisions of Section 4(b), other than an isolated, insubstantial and
          inadvertent failure not occurring in bad faith and which is remedied
          by the Company promptly after receipt of notice thereof given by the
          Executive;

               (iii)  the Company's requiring the Executive to be based at any
          office or location other than that described in Section 4(a)(i)(B);

               (iv) any purported termination by the Company of the Executive's
          employment otherwise than as expressly permitted by this Agreement; or

               (v) any failure by the Company to comply with and satisfy Section
          10(c).

For purposes of this Section 5(c), any good faith determination of "Good Reason"
made by the Executive shall be conclusive.

                                       8
<PAGE>   9

          (d) NOTICE OF TERMINATION.  Any termination by the Company for Cause,
     or by the Executive without any reason during the Window Period or for Good
     Reason, shall be communicated by Notice of Termination to the other party
     hereto given in accordance with Section 11(b).  For purposes of this
     Agreement, a "Notice of Termination" means a written notice which (i)
     indicates the specific termination provision in this Agreement relied upon,
     (ii) to the extent applicable, sets forth in reasonable detail the facts
     and circumstances claimed to provide a basis for termination of the
     Executive's employment under the provision so indicated and (iii) if the
     Date of Termination (as defined below) is other than the date of receipt of
     such notice, specifies the termination date (which date shall not be more
     than 15 days after the giving of such notice).  The failure by the
     Executive or the Company to set forth in the Notice of Termination any fact
     or circumstance which contributes to a showing of Good Reason or Cause
     shall not waive any right of the Executive or the Company hereunder or
     preclude the Executive or the Company from asserting such fact or
     circumstance in enforcing the Executive's or the Company's rights
     hereunder.

          (e) DATE OF TERMINATION.  "Date of Termination" means (i) if the
     Executive's employment is terminated by the Company for Cause, or by the
     Executive during the Window Period or for Good Reason, the date of receipt
     of the Notice of Termination or any later date specified therein, as the
     case may be, (ii) if the Executive's employment is terminated by the
     Company other than for Cause or Disability, the Date of Termination shall
     be the date on which the Company notifies the Executive of such termination
     and (iii) if the Executive's employment is terminated by reason of death or
     Disability, the Date of Termination shall be the date of death of the
     Executive or the Disability Effective Date, as the case may be.

     6.   OBLIGATIONS OF THE COMPANY UPON TERMINATION.

          (a) GOOD REASON OR DURING THE WINDOW PERIOD; OTHER THAN FOR CAUSE,
     DEATH OR DISABILITY.  If, during the Employment Period, the Company shall
     terminate the Executive's employment other than for Cause or Disability or
     the Executive shall terminate employment either for Good Reason or without
     any reason during the Window Period:

               (i) the Company shall pay to the Executive in a lump sum in cash
          within 30 days after the Date of Termination the aggregate of the
          following amounts:

                    A. the sum of (1) the amount of any Compensation for
               services rendered previously earned through the Date of
               Termination to the extent not theretofore paid and (2) any
               compensation previously deferred by the Executive (together with
               any accrued interest or earnings thereon) and any

                                       9
<PAGE>   10

               accrued vacation pay, in each case to the extent not theretofore
               paid (the sum of the amounts described in clauses (1) and (2)
               shall be hereinafter referred to as the "Accrued Obligations" and
               are hereby agreed to constitute reasonable compensation for
               services rendered); and

                    B. two hundred, ninety-nine percent (299%) of the
               Executive's Annual Base Salary and Annual Bonus as of the Date of
               Termination (the "Severance Amount").

               (ii) for the remainder of the Employment Period, or such longer
          period as any plan, program, practice or policy may provide, the
          Company shall continue benefits to the Executive and/or the
          Executive's family at least equal to those which would have been
          provided to them in accordance with the plans, programs, practices and
          policies described in Section 4(b)(v) if the Executive's employment
          had not been terminated in accordance with the most favorable plans,
          practices, programs or policies of the Company and its affiliated
          companies as in effect and applicable generally to other peer
          executives and their families during the 90-day period immediately
          preceding the Effective Date or, if more favorable to the Executive,
          as in effect generally at any time thereafter with respect to other
          peer executives of the Company and its affiliated companies and their
          families, provided, however, that if the Executive becomes reemployed
          with another employer and is eligible to receive medical and other
          welfare benefits under another employer provided plan, the medical and
          other welfare benefits described herein shall be secondary to those
          provided under such other plan during such applicable period of
          eligibility (such continuation of such benefits for the applicable
          period herein set forth shall be hereinafter referred to as "Welfare
          Benefit Continuation"). For purposes of determining eligibility of the
          Executive for retiree benefits pursuant to such plans, practices,
          programs and policies, the Executive shall be considered to have
          remained employed until the end of the Employment Period and to have
          retired on the last day of such period; and

               (iii)  to the extent not theretofore paid or provided, the
          Company shall timely pay or provide to the Executive and/or the
          Executive's family any other amounts or benefits required to be paid
          or provided or which the Executive and/or the Executive's family is
          eligible to receive pursuant to this Agreement and under any plan,
          program, policy or practice or contract or agreement of the Company
          and its affiliated companies as in effect and applicable generally to
          other peer executives and their families during the 90-day period
          immediately preceding the Effective Date or, if more favorable to the
          Executive, as in effect generally thereafter with respect to other
          peer executives of the Company and its affiliated companies and their
          families (such other amounts and benefits shall be hereinafter
          referred to as the "Other Benefits"); and

                                      10
<PAGE>   11

               (iv) any stock options held by the Executive pursuant to the 1989
          Long Term Incentive Stock Option Agreement or any other stock option
          agreement with Company (the "Option Agreements") shall remain
          exercisable following the Effective Date and during the Employment
          Period notwithstanding any provision in the Option Agreements to the
          contrary.  Further, any covenant not to compete in an Option Agreement
          shall become null and void as of the Effective Date.  Notwithstanding
          any provision herein deemed to be to the contrary, nothing herein
          shall extend the maximum period of time in which the Executive shall
          have the right to exercise such options.

          (b) DEATH.  If the Executive's employment is terminated by reason of
     the Executive's death during the Employment Period, this Agreement shall
     terminate without further obligations to the Executive's legal
     representatives under this Agreement, other than for (i) payment of Accrued
     Obligations (which shall be paid to the Executive's estate or beneficiary,
     as applicable, in a lump sum in cash within 30 days of the Date of
     Termination) and the timely payment or provision of the Welfare Benefit
     Continuation and Other Benefits (excluding, in each case, Death Benefits
     (as defined below)) and (ii) payment to the Executive's estate or
     beneficiary, as applicable, in a lump sum in cash within 30 days of the
     Date of Termination of an amount equal to the Severance Amount.

          (c) DISABILITY.  If the Executive's employment is terminated by reason
     of the Executive's Disability during the Employment Period, this Agreement
     shall terminate without further obligations to the Executive, other than
     for (i) payment of Accrued Obligations (which shall be paid to the
     Executive in a lump sum in cash within 30 days of the Date of Termination)
     and the timely payment or provision of the Welfare Benefit Continuation and
     Other Benefits (excluding, in each case, Disability Benefits (as defined
     below)) and (ii) payment to the Executive in a lump sum in cash within 30
     days of the Date of Termination of an amount equal to the greater of (A)
     the Severance Amount and (B) the present value (determined as provided in
     Section 280G(d)(4) of the Code) of any cash amount to be received by the
     Executive as a disability benefit pursuant to the terms of any plan, policy
     or arrangement of the Company and its affiliated companies, but not
     including any proceeds of disability insurance covering the Executive to
     the extent paid for directly or on a contributory basis by the Executive
     (which shall be paid in any event as an Other Benefit) (the benefits
     included in this clause (B) shall be hereinafter referred to as the
     "Disability Benefits").

          (d) CAUSE; OTHER THAN FOR GOOD REASON.  If the Executive's employment
     shall be terminated for Cause during the Employment Period, this Agreement
     shall terminate without further obligations to the Executive other than the
     obligation to pay to the Executive Annual Base Salary through the Date of
     Termination plus the amount of any compensation previously deferred by the
     Executive, in each case to the extent theretofore

                                      11
<PAGE>   12

     unpaid. If the Executive terminates employment during the Employment
     Period, excluding a termination either for Good Reason or without any
     reason during the Window Period, this Agreement shall terminate without
     further obligations to the Executive, other than for Accrued Obligations
     and the timely payment or provision of Other Benefits. In such case, all
     Accrued Obligations shall be paid to the Executive in a lump sum in cash
     within 30 days of the Date of Termination.

     7.   NON-EXCLUSIVITY OF RIGHTS.  Except as provided in Sections 6(a)(ii),
6(b) and 6(c), nothing in this Agreement shall prevent or limit the Executive's
continuing or future participation in any plan, program, policy or practice
provided by the Company or any of its affiliated companies and for which the
Executive may qualify, nor shall anything herein limit or otherwise affect such
rights as the Executive may have under any contract or agreement with the
Company or any of its affiliated companies.  Amounts which are vested benefits
or which the Executive is otherwise entitled to receive under any plan, policy,
practice or program of or any contract or agreement with the Company or any of
its affiliated companies at or subsequent to the Date of Termination shall be
payable in accordance with such plan, policy, practice or program or contract or
agreement except as explicitly modified by this Agreement.

     8.   FULL SETTLEMENT; RESOLUTION OF DISPUTES.

          (a) The Company's obligation to make the payments provided for in this
     Agreement and otherwise to perform its obligations hereunder shall not be
     affected by any set-off, counterclaim, recoupment, defense or other claim,
     right or action which the Company may have against the Executive or others,
     except as provided in Section 8(b) of this Agreement. In no event shall the
     Executive be obligated to seek other employment or take any other action by
     way of mitigation of the amounts payable to the Executive under any of the
     provisions of this Agreement and, except as provided in Section 6(a)(ii),
     such amounts shall not be reduced whether or not the Executive obtains
     other employment. The Company agrees to pay promptly as incurred, to the
     full extent permitted by law, all legal fees and expenses which the
     Executive may reasonably incur as a result of any contest (regardless of
     the outcome thereof) by the Company, the Executive or others of the
     validity or enforceability of, or liability under, any provision of this
     Agreement or any guarantee of performance thereof (including as a result of
     any contest by the Executive about the amount of any payment pursuant to
     this Agreement), plus in each case interest on any delayed payment at the
     applicable Federal rate provided for in Section 7872(f)(2)(A) of the Code.

          (b) If there shall be any dispute between the Company and the
     Executive (i) in the event of any termination of the Executive's employment
     by the Company, whether such termination was for Cause, or (ii) in the
     event of any termination of employment by the Executive, whether Good
     Reason existed, then, unless and until there is a final, nonappealable
     judgment by a court of competent jurisdiction declaring that such

                                      12
<PAGE>   13

     termination was for Cause or that the determination by the Executive of the
     existence of Good Reason was not made in good faith, the Company shall pay
     all amounts, and provide all benefits, to the Executive and/or the
     Executive's family or other beneficiaries, as the case may be, that the
     Company would be required to pay or provide pursuant to Section 6(a) as
     though such termination were by the Company without Cause or by the
     Executive with Good Reason; provided, however, that the Company shall not
     be required to pay any disputed amounts pursuant to this paragraph except
     upon receipt of an undertaking by or on behalf of the Executive to repay
     all such amounts to which the Executive is ultimately adjudged by such
     court not to be entitled.

     9.   LIMITATION ON AMOUNTS TO BE RECEIVED.  Notwithstanding anything to the
contrary herein contained, if any amount payable to the Executive or for his
benefit pursuant to the terms of this Agreement or otherwise would not be
deductible by the Company by reason of Section 280G of the Internal Revenue
Code, as amended from time to time, or any regulations promulgated pursuant
thereto, then such amount shall not be paid to the extent that it would cause
the aggregate amount payable by the Company to the Executive or for his benefit
pursuant to the terms of this Agreement or otherwise to exceed the amount which
may be paid without causing a loss of deduction under said Section 280G.  The
Executive shall determine which of the amounts payable under this Agreement
shall be eliminated or reduced consistent with the requirements of this Section
9; provided, however, that, if the Executive does not make such determination
within ten (10) business days of receipt by the Executive of a notice from the
Company or its agent (including, without limitation, attorneys or accountants)
indicating that the amount deductible under Section 280G would be exceeded by
the amounts payable to the Executive under this Agreement or otherwise, then the
Company shall elect which of the amounts payable under this Agreement shall be
eliminated or reduced consistent with the requirements of this Section 9 and
shall notify the Executive promptly of such election.

     10.  SUCCESSORS.

          (a) This Agreement is personal to the Executive and without the prior
     written consent of the Company shall not be assignable by the Executive
     otherwise than by will or the laws of descent and distribution.  This
     Agreement shall inure to the benefit of and be enforceable by the
     Executive's legal representatives.

          (b) This Agreement shall inure to the benefit of and be binding upon
     the Company and its successors and assigns.

          (c) The Company will require any successor (whether direct or
     indirect, by purchase, merger, consolidation or otherwise) to all or
     substantially all of the business and/or assets of the Company to assume
     expressly and agree to perform this Agreement in the same manner and to the
     same extent that the Company would be required to perform it if no such
     succession had taken place.

                                      13
<PAGE>   14

     11.  MISCELLANEOUS.

          (a) This Agreement shall be governed by and construed in accordance
     with the laws of the State of Delaware, without reference to principles of
     conflict of laws.  The captions of this Agreement are not part of the
     provisions hereof and shall have no force or effect.  This Agreement may
     not be amended or modified otherwise than by a written agreement executed
     by the parties hereto or their respective successors and legal
     representatives.

          (b) All notices and other communications hereunder shall be in writing
     and shall be given by hand delivery to the other party or by registered or
     certified mail, return receipt requested, postage prepaid, addressed as
     follows:

               If to the Executive:    D. Paul Jones, Jr.

                                       -----------------------------------------

                                       -----------------------------------------

                                       -----------------------------------------

               If to the Company:      Compass Bancshares, Inc.
                                       15 South 20th Street
                                       Birmingham, Alabama 35233

               Attention:              D. Paul Jones, Jr.

     or to such other address as either party shall have furnished to the other
     in writing in accordance herewith.  Notice and communications shall be
     effective when actually received by the addressee.

          (c) The invalidity or unenforceability of any provision of this
     Agreement shall not affect the validity or enforceability of any other
     provision of this Agreement.

          (d) The Company may withhold from any amounts payable under this
     Agreement such Federal, state or local taxes as shall be required to be
     withheld pursuant to any applicable law or regulation.

          (e) The Executive's or the Company's failure to insist upon strict
     compliance with any provision hereof or any other provision of this
     Agreement or the failure to assert any right the Executive or the Company
     may have hereunder, including, without limitation, the right of the
     Executive to terminate employment for Good Reason pursuant

                                      14
<PAGE>   15

     to Section 5(c)(i)-(v), shall not be deemed to be a waiver of such
     provision or right or any other provision or right of this Agreement.

          (f) The Executive and the Company acknowledge that, except as may
     otherwise be provided under any other written agreement between the
     Executive and the Company, the employment of the Executive by the Company
     is "at will" and, prior to the Effective Date, may be terminated by either
     the Executive or the Company at any time.  Moreover, if prior to the
     Effective Date, the Executive's employment with the Company terminates,
     then the Executive shall have no further rights under this Agreement.

     IN WITNESS WHEREOF, the Executive has hereunto set the Executive's hand
and, pursuant to the authorization from its Board of Directors, the Company has
caused these presents to be executed in its name on its behalf, all as of the
day and year first above written.

WITNESS:                            EXECUTIVE:

-----------------------------       -----------------------------
                                    D. Paul Jones, Jr.

ATTEST:                             COMPASS BANCSHARES, INC.

By:__________________________       By:_________________________
Its:_________________________       Title:______________________

                                       15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00009-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00009-of-00352.parquet"}]]